HPV-associated diseases in women and men: principles for diagnosis, treatment, prevention
https://doi.org/10.21518/2079-701X-2019-7-82-86
Abstract
Human papillomavirus infection in women and men causes benign, premalignant and malignant diseases of the anogenital area. Laboratory diagnosis plays a major role in early detection of HPV-associated diseases in women, but there are no approved screening modalities, which can detect HPV-associated diseases in men. Examination of the sexual partners of patients with anogenital HPV diseases is a substantiated and important link in a chain of cancer prevention methods.
About the Authors
N. M. Nazarova
Federal State Budgetary Institution «National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov» of the Ministry of Health of the Russian Federation.
Russian Federation
Russian Federation
Nazarova Niso Mirzoevna – Dr. of Sci. (Med.), Leading Researcher.
117997, Russia, Moscow, 4 Oparina St.
S. V. Pavlovich
Federal State Budgetary Institution «National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov» of the Ministry of Health of the Russian Federation.
Russian Federation
Russian Federation
Pavlovich Stanislav Vladislavovich – Cand. of Sci. (Med.), Associate Professor.
117997, Russia, Moscow, 4 Oparina St.
D. I. Attoeva
Federal State Budgetary Institution «National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov» of the Ministry of Health of the Russian Federation.
Russian Federation
Russian Federation
Attoeva Dzhamilya Ismailovna – a postgraduate student.
117997, Russia, Moscow, 4 Oparina St.
References
1. http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-key-statistics.
2. http://www.cancer.org/cancer/analcancer/detailedguide/anal-cancer-what-is-key-statistics.
3. Cancer Statistics. Surveillance Epidemiology and End Results, National Cancer Institute. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Retrieved October 22, 2013.
4. De Sanjose S. et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective crosssectional worldwide study. Lancet Oncol. 2010;11(11):1048–56. doi: 10.1016/S1470-2045(10)70230-8 PMID: 20952254.
5. Schiffman M., Wentzensen N. From Human papillomavirus to cervical cancer. Obstet Gynecol. 2010;116(1):177-85.
6. De Sanjose S., Quint W.G., Alemany L. et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048.
7. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol.2012;137:516-42.
8. Шуршалина А.В., Кречетова Л.В., Зиганшина М.М. Влияние эпигена на систему матриксных металлопротеиназ при вирусных инфекциях половых органов. Российский вестник акушера-гинеколога. 2009;2:21-24. [Shurshalina A.V., Krechetova L.V., Ziganshina M.M. Effect of epigenes on the matrix metalloproteinases system in viral infections of genital tract. Rossiysky Vestnik Akushera-Ginekologa2009;2:21-24.] (In Russ).
9. Роговская С.И., Шарогородская А.В., Бенева Т.Н. Повышение эффективности лечения заболеваний шейки матки: изучение опыта применения глицирризиновой кислоты. Многоцентровое ретроспективное исследование. Российский вестник акушера-гинеколога. 2011;5:98-101. [Rogovskaya S.I., Sharogorodskaya A.V., Beneva T.N. Improving the effectiveness of treatment of cervix uteri diseases: experience in using glycyrrhizic acid. Multicenter retrospective study. Rossiysky Vestnik Akushera-Ginekologa. 2011;5:98-101.] (In Russ).
10. Шарогородская А.В. Клинико-эпидемиологические особенности папилломавирусной инфекции у молодых женщин. ГБОУ ВПО Первый МГМУ имени И.М. Сеченова Минздрава России, 2013. Диссертация. [Sharogorodskaya A.V. Clinical and epidemiological features of human papillomavirus infection in young women. Sechenov First Moscow Medical University of the Ministry of Health of Russia, 2013. Thesis.] (In Russ).
11. HPV and Men - Fact SheetCenters for Disease Control and Prevention (СDС), February 4, 2015. Папилломавирусная инфекция (ВПЧ) у мужчин. Вопросы и ответы. Официальная позиция CDC (Национального центра по контролю и профилактике заболеваний), США, 2015. [HPV and Men – Fact Sheet Centers for Disease Control and Prevention (СДС), February 4, 2015. Human papillomavirus infection (HPV) in men. Questions and answers. The official position of the CDC (National Center for Disease Control and Prevention), USA, 2015.] (In Russ).
12. Профилактика рака шейки матки. Руководство для врачей. Под редакцией Г.Т. Сухих и В.Н. Прилепской. М.: МЕД-прессинформ, 2012. [Prevention of cervical cancer. A guide for practitioners. Under the editorship of Sukhikh G.T. and Prilepsky V.N. M.: MED-pressinform, 2012.] (In Russ)
Review
For citations:
Nazarova NM, Pavlovich SV, Attoeva DI. HPV-associated diseases in women and men: principles for diagnosis, treatment, prevention. Meditsinskiy sovet = Medical Council. 2019;(7):82-86. (In Russ.) https://doi.org/10.21518/2079-701X-2019-7-82-86
Views:
1286
Email this article 